Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1341, 2011-01, pp. : 24-25
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Natalizumab: First report of malignant melanoma: 2 case reports
Reactions Weekly, Vol. 1, Iss. 1189, 2008-01 ,pp. :
Access to resources
Recommend
Alemtuzumab: Malignant melanoma: case report
Reactions Weekly, Vol. 1, Iss. 1250, 2009-01 ,pp. :
Tocilizumab: First report of malignant melanoma: case report
Reactions Weekly, Vol. 1, Iss. 1418, 2012-01 ,pp. :
Infliximab: Malignant melanoma in an elderly patient: case report
Reactions Weekly, Vol. 1, Iss. 1261, 2009-01 ,pp. :
Immunosuppressants: Fatal malignant melanoma: case report
Reactions Weekly, Vol. 1, Iss. 1200, 2008-01 ,pp. :